Using telehealth to improve screening and treatment for alcohol use disorder
A Telehealth Intervention to Increase Screening and Treatment for Alcohol Use Disorder
This study is testing a helpful app that supports people with liver issues by making it easier for them to get screened and treated for alcohol use problems, with the goal of reducing their drinking and improving their health.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ria Technology Management INC. NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10924029 on NIH RePORTER |
What this research studies
This research investigates a telehealth intervention designed to enhance the screening and treatment of alcohol use disorder among patients with elevated liver function tests. The approach involves utilizing an app for twice-daily breathalyzer measures, physician-supervised medications, and personalized coaching. Patients identified through electronic health records will be invited to participate in screening and treatment, aiming to reduce alcohol consumption significantly. The program has already shown promising results with previous participants, indicating a potential for effective intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old with elevated liver function tests who may be at risk for alcohol use disorder.
Not a fit: Patients who do not have elevated liver function tests or do not struggle with alcohol use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved identification and treatment of alcohol use disorder, ultimately reducing alcohol-related health issues.
How similar studies have performed: Previous research has demonstrated success with telehealth interventions for alcohol use disorder, indicating a promising avenue for this approach.
Where this research is happening
San Francisco, United States
- Ria Technology Management INC. — San Francisco, United States (Active)
Researchers
- Principal investigator: Mendelson, John E. — Ria Technology Management INC.
- Study coordinator: Mendelson, John E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.